Gabapentin
- Product NDC
- 68788-7847
- 11-digit product format
- 687887847
- Labeler code
- 68788
- Product ID
- 68788-7847_79a177b5-7d19-430b-99e3-14ff7b66dc34
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA205101
- Marketing category
- ANDA
- Marketing start
- 2021-01-21
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68788-7847 | GABAPENTIN TABLET [PREFERRED PHARMACEUTICALS INC.] | 4 | Legacy NDC | 20240531_8cb353e4-ee6b-42d6-beb8-2ed905bd7d6a.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7847-1 | 68788784701 | 100 TABLET in 1 BOTTLE (68788-7847-1) | 100 tablet | 2021-01-21 | 0000-00-00 | No | No | Current |
| 68788-7847-3 | 68788784703 | 30 TABLET in 1 BOTTLE (68788-7847-3) | 30 tablet | 2021-01-21 | 0000-00-00 | No | No | Current |
| 68788-7847-6 | 68788784706 | 60 TABLET in 1 BOTTLE (68788-7847-6) | 60 tablet | 2021-01-21 | 0000-00-00 | No | No | Current |
| 68788-7847-8 | 68788784708 | 120 TABLET in 1 BOTTLE (68788-7847-8) | 120 tablet | 2021-01-21 | 0000-00-00 | No | No | Current |
| 68788-7847-9 | 68788784709 | 90 TABLET in 1 BOTTLE (68788-7847-9) | 90 tablet | 2021-01-21 | 0000-00-00 | No | No | Current |